Annual Shareholders Equity
$46.17 M
+$66.98 M+321.89%
December 31, 2023
Summary
- As of February 8, 2025, ALIM annual stockholders equity is $46.17 million, with the most recent change of +$66.98 million (+321.89%) on December 31, 2023.
- During the last 3 years, ALIM annual shareholders equity has risen by +$54.15 million (+678.72%).
Performance
ALIM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$38.79 M
-$1.86 M-4.59%
June 30, 2024
Summary
- As of February 8, 2025, ALIM quarterly stockholders equity is $38.79 million, with the most recent change of -$1.86 million (-4.59%) on June 30, 2024.
- Over the past year, ALIM quarterly shareholders equity has dropped by -$10.05 million (-20.58%).
Performance
ALIM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ALIM Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +321.9% | -20.6% |
| 3 y3 years | +678.7% | +558.4% |
| 5 y5 years | +1596.2% | +699.0% |
ALIM Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -145.1% | -20.6% | -153.6% |
| 5 y | 5-year | at high | -145.1% | -20.6% | -153.6% |
| alltime | all time | -6.8% | -458.4% | -31.1% | -529.2% |
Alimera Sciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $38.79 M(-4.6%) |
| Mar 2024 | - | $40.65 M(-11.9%) |
| Dec 2023 | $46.17 M(-321.9%) | $46.17 M(-5.5%) |
| Sep 2023 | - | $48.84 M(+5.6%) |
| Jun 2023 | - | $46.23 M(-344.4%) |
| Mar 2023 | - | -$18.92 M(-9.1%) |
| Dec 2022 | -$20.81 M(+698.8%) | -$20.81 M(+15.1%) |
| Sep 2022 | - | -$18.08 M(+46.6%) |
| Jun 2022 | - | -$12.34 M(+43.4%) |
| Mar 2022 | - | -$8.60 M(+230.2%) |
| Dec 2021 | -$2.60 M(-67.3%) | -$2.60 M(-273.4%) |
| Sep 2021 | - | $1.50 M(-74.5%) |
| Jun 2021 | - | $5.89 M(-149.3%) |
| Mar 2021 | - | -$11.96 M(+49.9%) |
| Dec 2020 | -$7.98 M(+79.5%) | -$7.98 M(+4.5%) |
| Sep 2020 | - | -$7.63 M(+1.4%) |
| Jun 2020 | - | -$7.53 M(+39.3%) |
| Mar 2020 | - | -$5.40 M(+21.6%) |
| Dec 2019 | -$4.45 M(-263.3%) | -$4.45 M(-31.4%) |
| Sep 2019 | - | -$6.48 M(+75.9%) |
| Jun 2019 | - | -$3.68 M(-670.0%) |
| Mar 2019 | - | $646.00 K(-76.3%) |
| Dec 2018 | $2.72 M(-81.8%) | $2.72 M(-8.4%) |
| Sep 2018 | - | $2.97 M(-46.4%) |
| Jun 2018 | - | $5.54 M(-35.2%) |
| Mar 2018 | - | $8.55 M(-42.7%) |
| Dec 2017 | $14.92 M(-41.7%) | $14.92 M(-28.1%) |
| Sep 2017 | - | $20.76 M(-4.3%) |
| Jun 2017 | - | $21.70 M(+8.2%) |
| Mar 2017 | - | $20.07 M(-21.6%) |
| Dec 2016 | $25.59 M | $25.59 M(-14.8%) |
| Sep 2016 | - | $30.03 M(+154.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $11.80 M(-30.1%) |
| Mar 2016 | - | $16.89 M(-35.8%) |
| Dec 2015 | $26.32 M(-46.8%) | $26.32 M(-21.1%) |
| Sep 2015 | - | $33.36 M(+0.1%) |
| Jun 2015 | - | $33.33 M(-17.8%) |
| Mar 2015 | - | $40.57 M(-18.1%) |
| Dec 2014 | $49.52 M(-1105.5%) | $49.52 M(+502.2%) |
| Sep 2014 | - | $8.22 M(-39.8%) |
| Jun 2014 | - | $13.66 M(+28.2%) |
| Mar 2014 | - | $10.65 M(-316.3%) |
| Dec 2013 | -$4.92 M(-112.6%) | -$4.92 M(-153.5%) |
| Sep 2013 | - | $9.20 M(-7.8%) |
| Jun 2013 | - | $9.97 M(-61.3%) |
| Mar 2013 | - | $25.74 M(-34.3%) |
| Dec 2012 | $39.14 M(+56.7%) | $39.14 M(+231.8%) |
| Sep 2012 | - | $11.80 M(-30.0%) |
| Jun 2012 | - | $16.85 M(-19.6%) |
| Mar 2012 | - | $20.97 M(-16.1%) |
| Dec 2011 | $24.98 M(-44.8%) | $24.98 M(-18.3%) |
| Sep 2011 | - | $30.59 M(-16.5%) |
| Jun 2011 | - | $36.65 M(-10.8%) |
| Mar 2011 | - | $41.06 M(-9.2%) |
| Dec 2010 | $45.21 M(-127.3%) | $45.21 M(-10.4%) |
| Sep 2010 | - | $50.44 M(-10.4%) |
| Jun 2010 | - | $56.30 M(-133.8%) |
| Mar 2010 | - | -$166.50 M(+0.6%) |
| Dec 2009 | -$165.47 M(+42.8%) | -$165.47 M(+17.2%) |
| Sep 2009 | - | -$141.18 M(+21.8%) |
| Dec 2008 | -$115.89 M(+142.8%) | -$115.89 M(+29.2%) |
| Jun 2008 | - | -$89.70 M(+8.8%) |
| Mar 2008 | - | -$82.47 M |
| Dec 2007 | -$47.74 M(+27.6%) | - |
| Dec 2006 | -$37.40 M | - |
FAQ
- What is Alimera Sciences annual stockholders equity?
- What is the all time high annual shareholders equity for Alimera Sciences?
- What is Alimera Sciences annual shareholders equity year-on-year change?
- What is Alimera Sciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Alimera Sciences?
- What is Alimera Sciences quarterly shareholders equity year-on-year change?
What is Alimera Sciences annual stockholders equity?
The current annual shareholders equity of ALIM is $46.17 M
What is the all time high annual shareholders equity for Alimera Sciences?
Alimera Sciences all-time high annual stockholders equity is $49.52 M
What is Alimera Sciences annual shareholders equity year-on-year change?
Over the past year, ALIM annual stockholders equity has changed by +$66.98 M (+321.89%)
What is Alimera Sciences quarterly stockholders equity?
The current quarterly shareholders equity of ALIM is $38.79 M
What is the all time high quarterly shareholders equity for Alimera Sciences?
Alimera Sciences all-time high quarterly stockholders equity is $56.30 M
What is Alimera Sciences quarterly shareholders equity year-on-year change?
Over the past year, ALIM quarterly stockholders equity has changed by -$10.05 M (-20.58%)